Kong Y, Li Z, Liu Y, Pan B, Fu X, Xiao R
Commun Biol. 2025; 8(1):299.
PMID: 39994346
PMC: 11850796.
DOI: 10.1038/s42003-025-07738-0.
Nisar H, Brauny M, Labonte F, Schmitz C, Konda B, Hellweg C
Int J Mol Sci. 2024; 25(23).
PMID: 39684302
PMC: 11641747.
DOI: 10.3390/ijms252312590.
Chang S, Moon R, Nam D, Lee S, Yoon I, Lee D
Nucleic Acids Res. 2024; 53(3).
PMID: 39660649
PMC: 11797049.
DOI: 10.1093/nar/gkae1210.
Ishikawa T, Matsuda M, Ishikawa H, Toyomura J, Ohyama A, Sakamoto N
Hum Cell. 2024; 38(1):22.
PMID: 39612090
DOI: 10.1007/s13577-024-01151-1.
Ding C, Xu X, Zhang X, Zhang E, Li S, Fan X
Sci Rep. 2024; 14(1):20083.
PMID: 39209895
PMC: 11362543.
DOI: 10.1038/s41598-024-70300-1.
Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?.
Liu Y, Lomeli I, Kron S
Cells. 2024; 13(15.
PMID: 39120312
PMC: 11312217.
DOI: 10.3390/cells13151281.
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment.
Zhang F, Guo J, Yu S, Zheng Y, Duan M, Zhao L
Cancer Commun (Lond). 2024; 44(9):929-966.
PMID: 38997794
PMC: 11492308.
DOI: 10.1002/cac2.12591.
Cell Senescence in Heterotopic Ossification.
Pignolo R, Kaplan F, Wang H
Biomolecules. 2024; 14(4).
PMID: 38672501
PMC: 11047966.
DOI: 10.3390/biom14040485.
Single-cell Landscape of Malignant Transition: Unraveling Cancer Cell-of-Origin and Heterogeneous Tissue Microenvironment.
Luo R, Liu J, Wen J, Zhou X
Res Sq. 2024; .
PMID: 38645221
PMC: 11030487.
DOI: 10.21203/rs.3.rs-4085185/v1.
Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9.
Yan F, Teng Y, Li X, Zhong Y, Li C, Yan F
Cancer Biol Ther. 2024; 25(1):2304161.
PMID: 38226837
PMC: 10793688.
DOI: 10.1080/15384047.2024.2304161.
Identification of hypoxia-related gene signatures based on multi-omics analysis in lung adenocarcinoma.
Luo Q, Li X, Meng Z, Rong H, Li Y, Zhao G
J Cell Mol Med. 2023; 28(2):e18032.
PMID: 38013642
PMC: 10826438.
DOI: 10.1111/jcmm.18032.
Hypoxic State of Cells and Immunosenescence: A Focus on the Role of the HIF Signaling Pathway.
Troise D, Infante B, Mercuri S, Netti G, Ranieri E, Gesualdo L
Biomedicines. 2023; 11(8).
PMID: 37626660
PMC: 10452839.
DOI: 10.3390/biomedicines11082163.
Circulating tumor cell-derived preclinical models: current status and future perspectives.
Kahounova Z, Pickova M, Drapela S, Bouchal J, Szczyrbova E, Navratil J
Cell Death Dis. 2023; 14(8):530.
PMID: 37591867
PMC: 10435501.
DOI: 10.1038/s41419-023-06059-6.
Endothelial Senescence and Its Impact on Angiogenesis in Alzheimer's Disease.
Georgieva I, Tchekalarova J, Iliev D, Tzoneva R
Int J Mol Sci. 2023; 24(14).
PMID: 37511104
PMC: 10379128.
DOI: 10.3390/ijms241411344.
Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis.
Phua T
Front Aging. 2023; 4:1196648.
PMID: 37384143
PMC: 10293850.
DOI: 10.3389/fragi.2023.1196648.
WNT-Conditioned Mechanism of Exit from Postchemotherapy Shock of Differentiated Tumour Cells.
Tsydenova I, Dolgasheva D, Gaptulbarova K, Ibragimova M, Tsyganov M, Kravtsova E
Cancers (Basel). 2023; 15(10).
PMID: 37345102
PMC: 10216216.
DOI: 10.3390/cancers15102765.
The hypoxia-inducible factor-1α in stemness and resistance to chemotherapy in gastric cancer: Future directions for therapeutic targeting.
Ozcan G
Front Cell Dev Biol. 2023; 11:1082057.
PMID: 36846589
PMC: 9945545.
DOI: 10.3389/fcell.2023.1082057.
Multiple characteristic alterations and available therapeutic strategies of cellular senescence.
Zhao Y, Li H, Guo Q, Hui H
J Zhejiang Univ Sci B. 2023; 24(2):101-114.
PMID: 36751697
PMC: 9936135.
DOI: 10.1631/jzus.B2200178.
Non-canonical approaches to targeting hypoxic tumors.
Zhao S, El-Deiry W
Am J Cancer Res. 2023; 12(12):5351-5374.
PMID: 36628275
PMC: 9827096.
Telomere Length Regulation.
Lansdorp P
Front Oncol. 2022; 12:943622.
PMID: 35860550
PMC: 9289283.
DOI: 10.3389/fonc.2022.943622.